Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2253-2258

  Seiler, Peter ^a,c   Kalinke, Ulrich ^a   Rülicke, Thomas ^b   Bucher, Etienne M ^a   Böse, Christian ^a,d   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS MENINGITIS; VIRUS NEUTRALIZATION;

EID: 0031910110     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2253-2258.1998     Document Type: Article

References (50)

1. Alberti, A., P. Pontisso, G. Tagariello, D. Cavalletto, L. Chemello, and F. Belussi. 1988. Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 25:1421-1424.
2. Andersson, B., A. C. Skoglund, M. Ronnholm, T. Lindsten, E. W. Lamon, E. W. Collisson, and A. S. Walia. 1981. Functional aspects of IgM and IgG Fc receptors on murine T lymphocytes. Immunol. Rev. 56:5-50.
3. Baer, G. M., W. J. Bellini, and D. B. Fishbein. 1990. Rhabdoviruses, p. 883-930. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York, N.Y.
4. Baldridge, J. R., and M. J. Buchmeier. 1992. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66:4252-4257.
5. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33:191-198.
6. Battegay, M., D. Kyburz, H. Hengartner, and R. M. Zinkernagel. 1993. Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur. J. Immunol. 23:3236-3241.
7. Battegay, M., D. Moskophidis, H. Waldner, M. A. Bründler, W. P. Fung-Leung, T. W. Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J. Immunol. 151:5408-5415.
8. Bründler, M.-A., P. Aichele, M. F. Bachmann, D. Kitamura, K. Rajewsky, and R. M. Zinkernagel. 1996. Immunity to viruses in B cell-deficient mice: influence of antibodies on virus persistence and on T cell memory. Eur. J. Immunol. 26:2257-2262.
9. Bruns, M., J. Cihak, G. Müller, and F. Lehmann-Grube. 1983. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization. Virology 130:247-251.
10. Buchmeier, M. J., H. A. Lewicki, O. Tomori, and M. B. A. Oldstone. 1981. Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology 113:73-85.
11. Cerny, A., A. W. Hügin, S. Sutter, H. Bazin, H. Hengartner, and R. M. Zinkernagel. 1986. Immunity to lymphocytic choriomeningitis virus in B cell-depleted mice: evidence for B cell and antibody independent protection by memory T cells. Eur. J. Immunol. 16:913-917.
12. Cerny, A., S. Sutter, H. Bazin, H. Hengartner, and R. M. Zinkernagel. 1988. Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice. J. Virol. 62:1803-1807.
13. Cole, G. A., N. Nathanson, and R. A. Prendergast. 1972. Requirement for thetabearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 238:335-337.
14. Corapi, W. V., C. W. Olsen, and F. W. Scott. 1992. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 66:6695-6705.
15. Halstead, S. B. 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481.
16. Homsy, J., M. Meyer, T. Tateno, S. Clarkson, and J. A. Levy. 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 244:1357-1360.
17. Hotchin, J. 1962. The biology of lymphocytic choriomeningitis infection: virus induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:479-499.
18. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K. J. Olsen, E. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
19. Kimmig, W., and F. Lehmann-Grube. 1979. The immune response of the mouse to lymphocytic choriomeningitis virus. I. Circulating antibodies. J. Gen. Virol. 45:703-710.
20. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
21. Kurane, I., and F. E. Ennis. 1992. Immunity and immunopathology in dengue virus infections. Semin, Immunol. 4:121-127.
22. Larsen, J. H. 1969. Development of humoral and cell-mediated immunity to lymphocytic choriomeningitis virus in the mouse. J. Immunol. 102:941-946.
23. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1-173.
24. Lemon, S. M., and D. L. Thomas. 1997. Vaccines to prevent viral hepatitis. N. Engl. J. Med. 336:196-204.
25. Lewis, R. M., T. M. Cosgriff, B. Y. Griffin, J. Rhoderick, and P. B. Jahrling. 1988. Immune serum increases arenavirus replication in monocytes. J. Gen. Virol. 69:1735-1739.
26. Lueseher, I. F., J. A. Loez, B. Malissen, and J. C. Cerottini. 1992. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling. J. Immunol. 148:1003-1011.
27. Moore, J. P., Y. Cao, D. D. Ho, and R. A. Koup. 1994. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1. J. Virol. 68:5142-5155.
28. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867-1874.
29. Moskophidis, D., F. Lechner, H. P. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-761.
30. Nemazee, D. A., and K. Bürki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562-566.
31. Ogra, P. L., M. Fishaut, and M. R. Gallagher. 1980. Viral vaccination via the mucosal routes. Rev. Infect. Dis. 2:352-369.
32. Pircher, H. P., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633.
33. Planz, O., P. Seiler, H. Hengartner, and R. M. Zinkernagel. 1996. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies. Nature 382:726-728.
34. Raghavan, M., and P. J. Bjorkman. 1996. Fc receptors and their interactions with immunoglobulins. Annu. Rev. Cell. Dev. Biol. 12:181-220.
35. Robert, G. M., M. Brown, and R. C. Gallo. 1985. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316: 72-74.
36. Sabin, A. B. 1981. Paralytic poliomyelitis: old dogmas and new perspectives. Rev. Infect. Dis. 3:543-564.
37. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H. Hengartner, and R. M. Zinkernagel. 1989. MHC dependent T cell epitopes of LCMV nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657-1667.
38. Seiler, P., M.-A. Bründler, C. Zimmerman, D. Weibel, M. Bruns, H. Hengartner, and R. M. Zinkernagel. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization. J. Exp. Med., in press.
39. Takeda, A., C. U. Tuazon, and F. A. Ennis. 1988. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science 242:580-583.
40. Thomsen, A. R., J. Johansen, O. Marker, and J. P. Christensen. 1996. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class 11-deficient mice and B cell-deficient mice. J. Immunol. 157:3074-3080.
41. Thomsen, A. R., and O. Marker. 1988. The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus. Immunology 65:9-15.
42. Traunecker, A., W. Luke, and K. Karjalainen. 1988. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 331:84-86.
43. Uher, F., I. Dobronyi, and J. Gergel. 1981. IgM-Fc receptor-mediated phagocytosis of rat macrophages. Immunology 42:419-425.
44. Webster, R. G., and R. Rott. 1987. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 50:665-666.
45. Weiss, R. A., P. R. Clapham, P. R. Cheingsong, A. G. Dalgleish, C. A. Carne, I. Weller, and R. S. Tedder. 1985. Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316:69-71.
46. Weiss, R. C., W. J. Dodds, and F. W. Scott. 1981. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparison with dengue hemorrhagic fever. Comp. Immunol. Microbiol. Infect. Dis. 4:175-189.
47. Wright, K. E., and M. J. Buchmeier. 1991. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J. Virol. 65:3001-3006.
48. Wright, T. L., and J. Y. N. Lau. 1993. Clinical aspects of hepatitis B virus infection. Lancet 342:1340-1344.
49. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173-178.
50. Zinkernagel, R. M., T. P. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162:2125-2141.